Profile data is unavailable for this security.
About the company
Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
- Revenue in USD (TTM)4.13bn
- Net income in USD543.80m
- Incorporated1990
- Employees7.07k
- LocationHologic Inc250 Campus DriveMARLBOROUGH 01752United StatesUSA
- Phone+1 (302) 658-7581
- Fax+1 (302) 655-5049
- Websitehttps://www.hologic.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Henry Schein Inc | 12.94bn | 391.00m | 9.20bn | 25.00k | 24.70 | 2.76 | 13.04 | 0.7115 | 3.17 | 3.17 | 104.73 | 28.35 | 1.19 | 4.86 | 7.60 | 517,520.00 | 3.70 | 5.43 | 6.36 | 9.19 | 31.19 | 30.23 | 3.10 | 3.98 | 0.7885 | 6.59 | 0.3872 | 0.00 | 2.71 | 4.88 | -6.25 | -11.06 | 19.66 | -- |
| Baxter International Inc | 11.02bn | -355.00m | 10.18bn | 38.00k | -- | 1.40 | 16.08 | 0.9237 | -0.6925 | -0.6654 | 21.46 | 14.09 | 0.4618 | 3.14 | 6.08 | 290,078.90 | -1.48 | -0.8441 | -1.87 | -1.03 | 35.05 | 38.63 | -3.20 | -2.03 | 1.18 | 3.42 | 0.5684 | -- | 2.66 | -1.31 | -293.68 | -- | -8.52 | 1.60 |
| Revvity Inc | 2.86bn | 239.88m | 10.89bn | 11.00k | 46.36 | 1.50 | 16.87 | 3.81 | 2.07 | 2.08 | 24.49 | 63.95 | 0.2326 | 3.46 | 4.15 | -- | 1.95 | 3.23 | 2.13 | 3.58 | 54.77 | 58.48 | 8.40 | 13.58 | 1.40 | 5.23 | 0.3075 | 8.52 | 3.67 | -5.47 | -15.26 | -19.91 | -1.05 | 0.00 |
| Globus Medical Inc | 2.77bn | 423.78m | 11.79bn | 5.30k | 28.47 | 2.70 | 16.84 | 4.26 | 3.09 | 3.09 | 20.09 | 32.68 | 0.5441 | 1.29 | 4.59 | 522,604.50 | 8.32 | 4.70 | 9.53 | 5.18 | 65.34 | 66.40 | 15.30 | 9.73 | 2.47 | 15.96 | 0.0002 | 0.00 | 60.62 | 26.25 | -16.19 | -7.88 | 10.29 | -- |
| Solventum Corp | 8.40bn | 1.52bn | 13.10bn | 22.00k | 8.69 | 2.63 | 6.41 | 1.56 | 8.69 | 8.69 | 48.01 | 28.75 | 0.5851 | 3.85 | 7.91 | 381,909.10 | 10.61 | -- | 13.32 | -- | 54.18 | -- | 18.13 | -- | 1.14 | 1.76 | 0.5075 | -- | 0.6954 | -- | -64.41 | -- | -- | -- |
| Penumbra Inc | 1.33bn | 164.03m | 13.31bn | 4.50k | 81.87 | 9.78 | 73.37 | 9.98 | 4.14 | 4.14 | 33.63 | 34.70 | 0.8276 | 1.07 | 7.42 | 296,399.60 | 10.18 | 1.42 | 11.31 | 1.58 | 66.80 | 63.21 | 12.30 | 1.96 | 4.18 | -- | 0.0171 | 0.00 | 12.86 | 16.89 | -84.59 | -21.98 | -0.853 | -- |
| Align Technology Inc | 4.03bn | 410.35m | 13.40bn | 20.95k | 33.01 | 3.31 | 32.68 | 3.32 | 5.66 | 5.66 | 55.58 | 56.43 | 0.6483 | 5.33 | 3.85 | -- | 6.59 | 8.11 | 9.67 | 11.97 | 68.25 | 70.40 | 10.17 | 12.31 | 1.24 | -- | -- | -- | 0.899 | 10.30 | -2.61 | -25.40 | -- | -- |
| Guardant Health Inc | 902.57m | -398.79m | 13.51bn | 2.00k | -- | -- | -- | 14.97 | -3.21 | -3.21 | 7.27 | -2.84 | 0.6411 | 4.02 | 8.85 | 451,510.30 | -28.33 | -24.20 | -33.49 | -26.83 | 63.76 | 63.23 | -44.18 | -91.24 | 3.12 | -10.70 | 1.47 | -- | 31.04 | 28.08 | 8.98 | -- | 10.58 | -- |
| Cooper Companies Inc | 4.09bn | 374.90m | 16.26bn | 15.00k | 44.29 | 1.97 | 21.62 | 3.97 | 1.87 | 1.87 | 20.46 | 42.06 | 0.3312 | 1.71 | 5.29 | 272,826.70 | 3.03 | 8.04 | 3.32 | 8.86 | 65.54 | 66.01 | 9.16 | 24.66 | 1.13 | 6.32 | 0.2332 | 0.2049 | 5.06 | 10.98 | -4.44 | 9.48 | 3.15 | -- |
| Hologic Inc | 4.13bn | 543.80m | 16.75bn | 7.07k | 31.14 | 3.19 | 19.96 | 4.06 | 2.41 | 2.41 | 18.28 | 23.51 | 0.4608 | 2.57 | 6.79 | 583,663.40 | 6.07 | 11.22 | 6.82 | 12.85 | 56.51 | 60.20 | 13.18 | 21.99 | 3.32 | 15.76 | 0.3246 | 0.00 | 1.74 | 1.66 | -28.35 | -12.69 | -0.5168 | -- |
| Insulet Corp | 2.52bn | 246.20m | 17.08bn | 3.90k | 70.43 | 12.34 | 51.17 | 6.77 | 3.45 | 3.45 | 34.85 | 19.68 | 0.833 | 1.62 | 6.02 | 646,641.00 | 8.13 | 6.00 | 10.05 | 7.03 | 71.46 | 67.05 | 9.76 | 9.22 | 2.18 | 27.39 | 0.423 | 0.00 | 22.07 | 22.92 | 102.76 | 104.84 | -4.75 | -- |
| Illumina Inc | 4.34bn | 850.00m | 17.86bn | 8.60k | 21.32 | 6.56 | 15.95 | 4.11 | 5.48 | 5.48 | 27.88 | 17.80 | 0.6709 | 2.61 | 5.34 | 505,000.00 | 13.13 | -10.15 | 17.32 | -12.15 | 66.61 | 65.39 | 19.57 | -23.18 | 1.72 | 15.79 | 0.4221 | -- | -0.6633 | 6.04 | 169.50 | 5.32 | -4.77 | -- |
| West Pharmaceutical Services Inc | 3.07bn | 493.70m | 18.04bn | 10.60k | 36.87 | 5.68 | 27.72 | 5.87 | 6.79 | 6.79 | 42.28 | 44.11 | 0.7769 | 4.80 | 5.46 | -- | 12.11 | 15.24 | 14.29 | 18.19 | 35.91 | 37.89 | 15.59 | 18.67 | 2.34 | -- | 0.06 | 9.99 | 6.25 | 7.44 | 0.203 | 7.36 | 10.39 | 5.51 |
| Zimmer Biomet Holdings Inc | 8.23bn | 705.00m | 19.11bn | 17.00k | 27.20 | 1.50 | 10.63 | 2.32 | 3.55 | 3.55 | 41.42 | 64.11 | 0.3703 | 1.10 | 5.17 | -- | 3.17 | 3.03 | 3.58 | 3.46 | 69.71 | 71.01 | 8.56 | 9.10 | 1.10 | 4.74 | 0.3718 | 29.10 | 7.20 | 6.08 | -21.98 | -- | 9.26 | 0.00 |
Data as of Feb 13 2026. Currency figures normalised to Hologic Inc's reporting currency: US Dollar USD
44.80%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2025 | 23.89m | 10.70% |
| T. Rowe Price Investment Management, Inc.as of 30 Sep 2025 | 21.55m | 9.65% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 12.86m | 5.76% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 9.88m | 4.42% |
| Manulife Investment Management (US) LLCas of 31 Dec 2025 | 9.44m | 4.23% |
| Geode Capital Management LLCas of 31 Dec 2025 | 5.92m | 2.65% |
| Victory Capital Management, Inc. (Investment Management)as of 31 Dec 2025 | 5.61m | 2.51% |
| Invesco Advisers, Inc.as of 30 Sep 2025 | 3.95m | 1.77% |
| Norges Bank Investment Managementas of 31 Dec 2025 | 3.82m | 1.71% |
| Invesco Capital Management LLCas of 30 Sep 2025 | 3.12m | 1.40% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
